✦ LIBER ✦

Refusal of treatment in a patient with fluctuating capacity - theory and practice

✍ Scribed by Mogg, Andrew; Bartlett, Annie

Book ID: 126519865
Publisher: Taylor and Francis Group
Year: 2005
Tongue: English
Weight: 106 KB
Volume: 16
Category: Article
ISSN: 1478-9949
DOI: 10.1080/14789940412331290049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The medical practice of patient autonomy

The medical practice of patient autonomy and cancer treatment refusals: a patients’ and physicians’ perspective

✍ Titia van Kleffens; Berna van Baarsen; Evert van Leeuwen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Refusal to Eat, Capacity, and Ethics in

Refusal to Eat, Capacity, and Ethics in Stroke Patients: A Report of 3 Cases

✍ Hillel M. Finestone; Jeff Blackmer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Diagnostic and treatment options in a pa

Diagnostic and treatment options in a papillary pelvic tumor patient with solitary kidney refusing nephrectomy

✍ Pál Bata; Attila Szendrői; Géza Tóth; Sándor Lovász; Attila Fintha; Imre Romics; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 809 KB

Urgent Assessment of Decision-Making Cap

Urgent Assessment of Decision-Making Capacity in a Patient With Schizophrenia and an Evolving Myocardial Infarction Who is Refusing Care

✍ Ackerman, Sean; Watkins, Matthew W.; Kostial, Amber F.; Rabinowitz, Terry 📂 Article 📅 2015 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 132 KB

THEORY AND PRACTICE IN RELATION TO THE T

THEORY AND PRACTICE IN RELATION TO THE TREATMENT OF CANCER WITH LEAD

✍ Bell, W.Blair 📂 Article 📅 1926 🏛 The Lancet 🌐 English ⚖ 391 KB

From Theory to Practice: Applying Curren

From Theory to Practice: Applying Current Clinical Knowledge and Treatment Strategies to the Care of Hemophilia A Patients With Inhibitors

✍ Edward D. Gomperts; Jan Astermark; Alessandro Gringeri; Jerome Teitel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Two bypassing agents are currently available to circumvent the need for factor FVIII in hemophilia A patients with inhibitors: the activated prothrombin complex FEIBA VH and recombinant activated factor VII (NovoSeven ® ). Both products are highly effective in controlling bleeding in the presence of